Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A and Ackerman L (1995) Antidepressant-induced mania and cycle acceleration: a controversy revisited.[see comment]. Am. J. Psychiatry 152, 1130-1138.
Benazzi F (1997) Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice. J. Affective Disord. 46, 73-77.
Bostwick JM & Pankratz VS. Affective disorders and suicide risk. Am. J. Psychiatry 157:1925-1932, 2000.
Cohen MM, Pettegrew JW, Kopp SJ, Minshew N and Glonek T (1984) P-31 nuclear magnetic resonance analysis of brain: normoxic and anoxic brain slices. Neurochem. Res. 9, 785-801.
Eisenmesser EZ, Millet O, Labeikovsky W, Korzhnev DM, Wolf-Watz M, Bosco DA, Skalicky JJ, Kay LE and Kern D. (2005) Intrinsic dynamics of an enzyme underlies catalysis. Nature 438, 117-121.
Geddes JW, Panchalingam K, Keller JN and Pettegrew JW (1997) Elevated phosphocholine and phosphatidyl choline following rat entorhinal cortex lesions. Neurobiol. Aging 18, 305-308.
Glonek T, Kopp SJ, Kot E, Pettegrew JW and Cohen MM (1982a) P-31 nuclear magnetic resonance analysis of brain. The perchloric acid extract spectrum. Trans. Am. Soc. Neurochem. 13, 143.
Glonek T, Kopp SJ, Kot E, Pettegrew JW, Harrison WH and Cohen MM (1982b) P-31 nuclear magnetic resonance analysis of brain: The perchloric acid extract spectrum. J. Neurochem. 39, 1210-1219.
Goodwin FK & Jamison KR. Manic Depressive Illness, New York, NY, Oxford University Press, 1990.
Grunze H, Kasper S, Goodwin G, et al., World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of bipolar disorder, part 1: treatment of bipolar depression. World J. Biol. Pschiatry 3:115-124, 2002.
Haung YJ and Montelione GT. (2005) Structural Biology: Proteins flex to function. Nature 438, 36-37.
Henry C, Sorbara F, Lacoste J, Gindre C and Leboyer M (2001) Antidepressant-induced mania in bipolar patients: identification of risk factors. J. Clin. Psychiatry 62, 249-255.
Herschfeld RMA, Bowden CL, Gitlin MJ, et al., Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 59:1-50, 2002.
Joffe RT, MacQueen GM, Marriott M, Robb J, Begin H and Young LT (2002) Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant. Acta Psychiatr. Scand. 105, 427-430.
Kanfer JN, Pettegrew JW, Moossy J and McCartney DG (1993) Alterations of selected enzymes of phospholipid metabolism in Alzheimer’s disease brain tissue as compared to non-Alzheimer’s disease controls. Neurochem. Res. 18, 331-334.
Keshavan MS, Pettegrew JW, Panchalingam K, Kaplan D and Bozik E (1991) Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia. Arch. Gen. Psychiatry 48, 1112-1113.
Keshavan MS, Stanley JA, Montrose DM, Minshew NJ and Pettegrew JW (2003) Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study. Molecular Psychiatry 8, 316-323.
Klunk WE, Xu C, Panchalingam K, McClure RJ and Pettegrew JW (1996) Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer’s disease brain. Neurobiol. Aging 17, 349-357.
Klunk WE, Panchalingam K, McClure RJ, Stanley JA and Pettegrew JW (1998) Metabolic alterations in postmortem Alzheimer’s disease brain are exaggerated by Apo-E4. Neurobiol. Aging 19, 511-515.
Levine J, Barak Y, Gonzalves M, Szor H, Elizur A, Kofman O, Belmaker and RH (1995) Double-blind, controlled trial of inositol treatment of depression. Am. J. Psychiatry 152, 792-794.
Murray CJL & Lopez AD (editors). The Global Burden of Disease, Cambridge, MA, Harvard University Press, 1996.
Pettegrew JW, Glonek T, Baskin F and Rosenberg RN (1978) Phosphorus-31 NMR of neuroblastoma clonal lines. Effect of cell cycle stage and dibutyryl cyclic AMP. Proc. 14th Midwest Regional Am. Chem. Soc. 45.
Pettegrew JW, Glonek T, Baskin F and Rosenberg RN (1979a) Phosphorus-31 NMR of neuroblastoma clonal lines: effect of cell confluency state and dibutyryl cyclic AMP. Neurochem. Res. 4, 795-801.
Pettegrew JW, Nichols JS and Stewart RM (1979b) Fluorescence spectroscopy on Huntington’s fibroblasts. J. Neurochem. 33, 905-911.
Pettegrew JW, Nichols JS and Stewart RM (1979c) Fluorescence studies of fibroblasts, lymphocytes, and erythrocytes in Huntington’s disease. Ann. Neurol. 6, 164.
Pettegrew JW, Nichols JS and Stewart RM (1980a) Membrane biophysical studies in manic-depressive intact peripheral tissues. Neurology 30, 375.
Pettegrew JW, Nichols JS and Stewart RM (1980b) Membrane studies in Huntington’s disease: steady-state fluorescence studies of intact erythrocytes. Ann. Neurol. 8, 381-386.
Pettegrew JW, Minshew NJ and Stewart RM (1981a) Dynamic membrane studies in individuals at risk for Huntington’s disease. Neurology 31, 151.
Pettegrew JW, Nichols JS and Stewart RM (1981b) Membrane studies in Huntington’s disease: Steady-state and time-dependent fluorescence spectroscopy of intact lymphocytes. J. Neurochem. 36, 1966-1976.
Pettegrew JW and Minshew NJ (1981c) Effects of short chain fatty acids on cellular membranes and energy metabolism: A nuclear magnetic resonance study. Neurology 31, 143.
Pettegrew JW, Minshew NJ, Glonek T, Kopp SJ and Cohen MM (1982a) Phosphorus NMR study of gerbil stroke model. Neurology 32, 196.
Pettegrew JW, Nichols JS, Minshew NJ, Rush AJ and Stewart RM (1982b) Membrane biophysical studies of lymphocytes and erythrocytes in manic-depressive illness. J. Affective Disord. 4, 237-247.
Pettegrew JW, Kopp SJ, Dadok J, Minshew NJ, Feliksik JM, Glonek T and Cohen MM (1986) Chemical characterization of a prominent phosphomonoester resonance from mammalian brain: 31P and 1H NMR analysis at 4.7 and 14.1 tesla. J. Magn. Reson. 67, 443-450.
Pettegrew JW, Kopp SJ, Minshew NJ, Glonek T, Feliksik JM, Tow JP and Cohen MM (1987a) 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: Preliminary observations. J. Neuropathol. Exp. Neurol. 46, 419-430.
Pettegrew JW, Short JW, Woessner RD, Strychor S, McKeag DW, Armstrong J, Minshew NJ and Rush AJ (1987b) The effect of lithium on the membrane molecular dynamics of normal human erythrocytes. Biol. Psychiatry 22, 857-871.
Pettegrew JW, Moossy J, Withers G, McKeag D and Panchalingam K (1988a) 31P Nuclear Magnetic Resonance study of the brain in Alzheimer’s disease. J. Neuropathol. Exp. Neurol. 47, 235-248.
Pettegrew JW, Panchalingam K, McClure RJ, Gershon S, Muenz LR and Levine J. (2001) Effects of chronic lithium administration on rat brain phosphatidylinositol cycle constituents, membrane phospholipids and amino acids. Bipolar Disorders 3, 189-201.
Pettegrew JW, Panchalingam K, Moossy J, Martinez J, Rao G and Boller F (1988b) Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer’s disease. Arch. Neurol. 45, 1093-1096.
Pettegrew JW, Panchalingam K, Spiker D, Minshew N, McKeag D, Strychor S and Tretta M (1988c) Membrane molecular dynamics in affective illness. Soc. Biol. Psychiatry,43rd Annual Convention/Scientific Program, p. 364.
Pettegrew JW, Panchalingam K, Withers G, McKeag D and Strychor S (1990a) Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat. J. Neuropathol. Exp. Neurol. 49, 237-249.
Pettegrew JW, Strychor S, Tretta M and McKeag D (1990b) Membrane molecular alterations in Alzheimer’s erythrocytes. Neurology 40 (Suppl. 1), 404.
Pettegrew JW, Strychor S, Tretta M and McKeag D (1990c) Membrane molecular alterations in Alzheimer’s erythrocytes (abstract). Neurology 40 (Suppl. 1), 404.
Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG and Allen M (1991) Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch. Gen. Psychiatry 48, 563-568.
Pettegrew JW, Minshew NJ, Spiker D, McClure RJ and Klunk WE (1993a) Membrane alterations in erythrocytes of affective illness patients. Biol. Psychiatry 33, 47A.
Pettegrew JW, Minshew NJ, Spiker D, Tretta M, Strychor S, McKeag D, Munez LR, Miller GM, Carbone D and McClure RJ (1993b) Alterations in membrane molecular dynamics in erythrocytes of patients with affective illness. Depression 1, 88-100.
Pettegrew JW, Panchalingam K, Klunk WE, McClure RJ and Muenz LR (1994) Alterations of cerebral metabolism in probable Alzheimer’s disease: A preliminary study. Neurobiol. Aging 15, 117-132.
Pettegrew JW, Klunk WE, Kanal E, Panchalingam K and McClure RJ (1995) Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia. Neurobiol. Aging 16, 973-975.
Pettegrew JW, Panchalingam K, McClure RJ, Gershon S, Muenz LR and Levine J (2001) Effects of chronic lithium administration on rat brain phosphatidylinositol cycle constituents, membrane phospholipids and amino acids. Bipolar Disorders, 3, 189-201.
Pettegrew JW, Levine J, Gershon S, Stanley JA, Servan-Schreiber D, Panchalingam K and McClure RJ (2002) 31P-MRS study of acetyl-L-carnitine treatment in geriatric depression: preliminary results. Bipolar Disorders 4, 61-66.
Ramasubbu R (2001) Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders. Acta Psychiatr. Scand. 104, 236-238.
Sachs GS, Printz DJ, Kahn DA, Carpenter D and Docherty JP. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder, Postgraduate Med. April, Spec:1-104, 2000.
Singh I, Xu C, Pettegrew JW and Kanfer JN (1994) Endogenous inhibitors of human choline acetyltransferase present in Alzheimer’s brain: Preliminary observation. Neurobiol. Aging 15, 643-649.
Sweet RA, Panchalingam K, Pettegrew JW, McClure RJ, Hamilton RL, Lopez OL, Kaufer DI, DeKosky ST and Klunk WE (2002) Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol. Aging 23, 547-553.
Tamada RS, Issler CK, Amaral JA, Sachs GS and Lafer B (2004) Treatment emergent affective switch: a controlled study. Bipolar Disorders 6, 333-337.